Lanreotide Autogel® in acromegaly: a guide to its use in the EU Lesley J. ScottCeleste B. BurnesssSusan J. Keam Adis Drug Q&A 05 November 2015 Pages: 409 - 416
Naltrexone ER/bupropion ER in obesity management: a guide to its use Sarah L. GreigGillian M. Keating Adis Drug Q&A 12 October 2015 Pages: 417 - 424
Azelastine hydrochloride/fluticasone propionate combined in a single nasal spray: a guide to its use in allergic rhinitis Greg L. PloskerKatherine A. Lyseng-Williamson Adis Drug Q&A 13 October 2015 Pages: 425 - 432
Adjust therapy for restless legs syndrome if symptoms worsen, efficacy is lost or iatrogenic augmentation develops Adis Medical Writers Disease Management 15 October 2015 Pages: 433 - 436
Cellulite: no clear evidence that any type of treatment is effective Adis Medical Writers Disease Management 11 September 2015 Pages: 437 - 440
First reports of adverse drug reactions in recent weeks Drug Reactions and Interactions 26 October 2015 Pages: 441 - 442
Preventative strategies may reduce the risk of chronic kidney disease in elderly patients receiving lithium Adis Medical Writers Drug Reactions and Interactions 30 September 2015 Pages: 443 - 447
Evaluation of ophthalmic adverse drug reactions at a tertiary-care hospital Jignesh PatelMira DesaiSamidh Shah Original Research Article 07 October 2015 Pages: 448 - 451
Quantitative and qualitative analysis of prescriptions at a tertiary-care hospital Moutusi SadhukhanBhavik ShahMira Desai Original Research Article 16 September 2015 Pages: 452 - 457
Erratum to: Pazopanib in advanced renal cell carcinoma: a guide to its use in the EU Katherine A. Lyseng-Williamson Erratum 09 November 2015 Pages: 458 - 458
